 |
 |
Introduction | Anatomy | Abstracting, Coding, & Staging | | Hands-on Exercise | | |||||||||
|
|||||||||||
| Treatment | Cancer Directed Surgery | | Unit Review | | |||||||||||
|
|
Introduction | Anatomy | Abstracting, Coding, & Staging | | Hands-on Exercise | | |||||||||
|
|||||||||||
| Treatment | Cancer Directed Surgery | | Unit Review | | |||||||||||
Chemotherapy for epithelial tumors
Melphalan (alone as primary adjuvant treatment)
Taxol
Ifosfamide (for recurrence)
Hexamethylmelamine (for recurrence)
Combinations
CAP (cytoxan, adriamycin, cisplatin)
CP (cytoxan and cisplatin)
CC (cytoxan and carboplatin)
H-CAP or CHAD (hexamethylmelamine, cytoxan, adriamycin, cisplatin)
AP (adriamycin and cisplatin)
HEXA-CAF (hexamethylmelamine, cytoxan, methotrexate, 5-FU)
Chemotherapy for germ cell tumors
VAC (vincristine, dactinomycin, cytoxan)
BEP (cisplatin, etoposide, bleomycin)
BVP (cisplatin, vinblastine and bleomycin)
VPP (etoposide and cisplatin)
Tamoxifen (for recurrence)
Autologous bone marrow transplant is under clinical evaluation as an adjunct to high dose chemotherapy.
Radiation therapy for epithelial ovarian cancers is reserved for treatment of metastases.
For germ cell tumors, prophylactic irradiation to the mediastinal and supraclavicular lymph nodes may be considered. Radioactive phosphorus (P32) can control ascites but causes adhesions and bowel complications.
